SR-16435 is a drug which acts as a potent partial agonist at both the μ-opioid receptor and nociceptin receptor.

In animal studies it was found to be a potent analgesic, with results suggestive of reduced development of tolerance and increased activity against neuropathic pain compared to classic μ-selective agonists.

[1][2][3] This pharmacology-related article is a stub.

You can help Wikipedia by expanding it.